Dr.Shilpa Singh

Dr. ANURAG NARULA, Dr. ANURAG NARULA

Abstract

Aim: The aim was to see the long term outcome of treatment of non invasive ocular

surface squamous neoplasia with topical Mitomycin C (0.02%) .

Materials and methods: Total 12 eyes of 10 patients were treated with topical

mitomycin C (0.02%) alone as a sole therapy. All patients received topical MMC (0.02%) four times

daily as a cycle therapy of 14 days treatment followed by no treatment for 28 days and one cycle lasting for 144 days. The patients were followed up to 18 months.

Results: All patients showed total response with no recurrence during follow up period.

Conclusion: Topical Mitomycin C (0.02%) may be used as a sole therapeutic

treatment of non invasive Ocular surface squamous neoplasia with good follow up.